- Posted on: Aug 10 2015
Dr. Pauline Merrill and her research team were announced as the #1 recruiting site in the world(out of 149 eligible sites!) for the SAKURA study.
The SAKURA study is a A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study for the Treatment of Active, Non-Infectious Uveitis. Uveitis is swelling of the middle later of the eye, which is called the “uvea”. Uveitis is a rare condition and it is classified based on the location of the inflammation. Phase III will evaluate the investigational drug sirolimus for the treatment of non infectious posterior uveitis.
Posted in: News and Events